OneSource Specialty Pharma Limited (NSE:ONESOURCE)

Market Cap	214.54B
Revenue (ttm)	14.80B
Net Income (ttm)	-126.10M
Shares Out	114.53M
EPS (ttm)	-1.19
PE Ratio	n/a
Forward PE	45.15
Dividend	n/a
Ex-Dividend Date	n/a

Volume	87,820
Average Volume	149,503
Open	1,885.10
Previous Close	1,879.50
Day's Range	1,858.70 - 1,900.00
52-Week Range	1,209.95 - 2,248.00
Beta	n/a
RSI	46.30
Earnings Date	Nov 4, 2025

About NSE:ONESOURCE

OneSource Specialty Pharma Limited, a biopharmaceutical company, engages in the research, development, manufacture, and commercialization of biological drug products in various injectable formats in India, Ireland, the United States of America, and internationally. The company provides end-to-end contract development and manufacturing operations (CDMO) services across various phases of preclinical and clinical development and commercial supply of biologics. It also offers drug-devices, including prefilled syringes, dial and push variable and fi...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2007
• Employees: 525
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: ONESOURCE

Financial Performance

In 2024, NSE:ONESOURCE's revenue was 14.45 billion, an increase of 740.43% compared to the previous year's 1.72 billion. Losses were -179.71 million, -95.41% less than in 2023.